Abstract
The clinical considerations that are important in selection and implementation of the induction and maintenance of anesthesia in the patient undergoing renal transplantation are generally still present at the time of recovery from anesthesia. This chapter will deal with clinical problems frequently encountered during the first 24 hours after renal transplantation. This is an arbitrary distinction but facilitates discussion of immediate postoperative and postanesthetic events. In “Anesthesia Related Morbidity” (chapter 13), events are covered which are likely to become manifest longer than 24 hours after renal transplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Drayer DE: Active drug metabolites in renal failure. Am J Med 62:486, 1977.
Maher JF: Pharmacokinetics in patients with renal failure. Clin Nephrol 21:39, 1984.
Grodstein G, Harrison A, Robert C, et al.: Impaired gastric emptying in hemodialysis patients (Abstract). Kidney Int 16:952A, 1979.
Weil R, Schroter GPJ, West JC, et al.: A fourteen year experience with kidney transplantation. World J of Surg 1:145, 1977.
Murray JE, Tilney NL, Wilson RE: Renal transplantation: a twenty-five year experience. Ann Surg 184:565, 1976.
Matas AJ, Simmons RL, Buselmeier TJ, et al.: The fate of patients surviving three years after renal transplantation. Surg 80:390, 1976.
Ivey GL, Richie RE, Niblack GD, et al.: Renal transplantation: a twenty year experience in a Veteran’s Administration Medical Center. Arch Surg 120:1021, 1985.
Aldrete JA, Daniel W, O’Higgins JW, et al.: Analysis of anesthetic-related morbidity in human recipients of renal homografts. Anesth Analg 50:321, 1971.
Miller RD, Cullen DJ: Renal failure and postoperative respiratory failure: recurarization? Br J Anaesth 48:253, 1976.
Sirotzky L, Lewis EJ: Anesthesia related muscle paralysis in renal failure. Clin Nephrol 10:38, 1978.
Abrams RE, Hornbein TF: Inability to reverse pancuronium blockade in a patient with renal failure and hepatic disease. Anesthesiology 42:362, 1975.
Bradley JP, Marslen AR, O’Connor JP: Prolonged neuromuscular blockade after renal transplantation. Anaesth Intensive Care 13:196, 1985.
Rouse JM, Galley RLA, Bevan DR: Prolonged curarisation following renal transplantation. Anaesthesia 32:247, 1977.
Ramsey FM, Lebowitz PW, Savarese JJ, et al.: Clinial characteristics of long-term succiny- lcholine neuromuscular blockade during balanced anesthesia. Anesth Analg 59:110, 1980.
Donati F, Bevan DR: Antagonism of phase II succinylcholine block by neostigmine. Anesth Analg 64:773, 1985.
Ryan DW: Preoperative serum cholinesterase concentration in chronic renal failure. Br J Anaesth 49:945, 1977.
Bishop MJ, Hornbein TF: Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure. Anesthesiology 58:384, 1983.
McLeod K, Watson MJ, Rawlings MD: Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Br J Anaesth 48:341, 1976.
Miller RD, Matteo RS, Benet LZ, et al.: The pharmacokinetics of d-tubocurarine in patients with and without renal failure. J Pharm Exp Ther 202:1, 1977.
Cohen EN, Brewer HW, Smith D: The metabolism and elimination of d-tubocurarine -H3. Anesthesiology 28:309, 1967.
Brooks DK, Feldman SA: Metabolic acidosis: a new approach to “neostigmine resistant curarisation.” Anaesthesia 17:161, 1962.
Riordan DD, Gilbertson AA: Prolonged curarization in a patient with renal failure. Br J Anaesth 43:506, 1971.
Gibaldi M, Levy G, Hayton WL: Tubocurarine and renal failure. Br J Anaesth 44:163, 1972.
Somogyi A A, Shanks CA, Triggs EJ: The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide. Eur J Clin Pharm 12:23, 1977.
Miller RD, Stevens WC, Way WL: The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man. Anesth Analg 52:661, 1973.
Bevan DR, Archer D, Donati F, et al.: Antagonism of pancuronium in renal failure: no re- curarization. Br J Anaesth 54:63, 1982.
Geha DG, Blitt CD, Moon BJ: Prolonged neuromuscular blockade with pancuronium in the presence of acute renal failure: a case report. Anesth Analg 55:343, 1976.
Meistelman C, Lienhart A, Leveque C, et al.: Pharmacology of vecuronium in patients with end-stage renal failure. Anesthesiology 59:A293, 1983.
Bencini AF, Scaf AHJ, Sohn YJ, et al.: Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 65:245, 1986.
Bevan DR, Donati F, Gyasi H, et al.: Vecuronium in renal failure. Can Anaesth So 31:491, 1984.
Fahey MR, Morris RB, Miller RD, et al.: Pharmacokinetics of Org NC45 (Norcuron) in patients with and without renal failure. Br J Anaesth 53:1049, 1981.
Hunter JM, Jones RS, Utting EE: Comparison of vecuronium, atracurium and tubocurarine in normal patients and patients with no renal function. Br J Anaesth 56:941, 1984.
Funk FJ, Crul JF, Vander Pol FM: Effects of changes in acid-base balance in neuromuscular blockade produced by ORG-NC45. Acta Anaesth Scand 24:119, 1980.
Gencarelli PJ, Swen J, Koot HWJ, et al.: The effects of hypercarbia and hypocarbia on pancuronium and vecuronium neuromuscular blockade in anesthetized humans. Anesthesiology 59:376, 1983.
Foldes FF, Bencini A, Newton D: Influence of halothane and enflurane on the neuromuscular blocking effects of Org NC45 in man. Br J Anaesth 52:64S, 1980.
Rupp SM, Miller RD, Gencarelli PJ: Vecuronium induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans. Anesthesiology 60:102, 1984.
Kreig N, Rutten JMJ, Crul JF, et al.: Preliminary review of the interactions of Org NC45 with anaesthetics and antibiotics in animals. Br J Anaesth 52:33S, 1980.
Hunter JM, Jones RS, Utting JE: Use of atracurium in patients with no renal function. Br J Anaesth 54:1251, 1982.
Fahey MR, Rupp SM, Fisher DM, et al.: Pharmacokinetics and pharmacodynamics of atracurium in normal and renal failure patients. Anesthesiology 59:A263, 1983.
Fahey MR, Rupp SM, Fisher DM, et al.: The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61:699, 1984.
Hughes R, Chappie DJ: The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Br J Anaesth 53:31, 1981.
Cronnelly R, Stanski DR, Miller RD, et al.: Renal function in the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 51:222, 1979.
Stanski DR, Miller RD, Sheiner LB. Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 51:222, 1979.
Cronnelly R, Stanski DR, Miller RD, et al.: Pyridostigmine kinetics with and without renal function. Clin Pharm Therap 28:78, 1980.
Morris RB, Cronnelly R, Miller RD, et al.: Pharmacokinetics of edrophonium in anephric and renal transplant patients. Br J Anaesth 53:1311, 1981.
Don HF, Dieppa RA, Taylor P: Narcotic analgesics in anuric patients. Anesthesiology 42:745, 1975.
Aitkenhead AR, Vater M, Achola K, et al.: Pharmacokinetics of single dose IV morphine in normal volunteers and patients with end-stage renal failure. Br J Anaesth 56:813, 1984.
Moore A, Sear J, Baldwin D, et al.: Morphine kinetics during and after renal transplantation. Clin Pharm Therap 35:641, 1984.
Sear J, Moore A, Hunniset A, et al.: Morphine kinetics and kidney transplantation: morphine removal is influenced by renal ischemia. Anesth Analg 64:1065, 1985.
Casthely PA, Villaneuva R: Level of consciousness after cadaveric kidney trasnsplant under halothane anesthesia. Can Anaesth So 30:587, 1983.
Wiggum DC, Cork RC, Weldon ST, et al.: Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure. Anesthesiology 63:708, 1985.
Lehmann CR, Heironimus JD, Collins CB, et al.: Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. Clin Pharm Therap 37:284, 1985.
Gifford RRM, Schmidtke JR, Ferguson RM: Cimetidine modulation of lymphocytes from renal allograft recipients. Transpl Proc 13:663, 1981.
Niessen GJCM, Obertop H, Kort WJ: Cimetidine and renal allograft survival. Surg 91:116, 1982.
Weir PHC, Chung FF: Anaesthesia for patients with chronic renal disease. Can Anesth Soc J 31:468, 1984.
Ghoneim MM, Pandya H: Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 42:545, 1975.
Dundee JW, Richards RK: Effect of azotemia upon the action of intravenous barbituate anesthesia. Anesthesiology 15:333, 1954.
Burch PG, Stanski DR: Pharmacokinetics of thiopental in renal failure. Anesthesiology 55:A176, 1981.
Bennett WM, Muther RS, Parker RA, et al.: Drug therapy in renal failure: Dosing guidelines for adults. Ann Intern Med 93:62 and 286, 1980.
Vinik R, Reves JG, Nixon D, et al.: Midazolam induction and emergence in renal failure patients. Anesthesiology 55:A262, 1981.
Miller RD, Sohn YJ, Matteo RS: Enhancement of d-tubocurarine neuromuscular blockade by diuretics in man. Anesthesiology 45:442, 1976.
Tilstone WJ, Fine A: Furosemide kinetics in renal failure. Clin Pharm Therap 23:644, 1978.
Berry AJ, Peterson ML: Hyponatremia after mannitol administration in the presence of renal failure. Anesth Analg 60:165, 1981.
Borges HF, Hocks J, Kjellstrand CM: Mannitol intoxication in patients with renal failure. Arch Intern Med 142:63, 1982.
Charters P: Mannitol, osmolality and steroids during renal transplantation. Anaesthesia 38:327, 1983.
Rauscher LA, Hurst JM, Collins GM: Nitroprusside toxicity in a renal transplant patient. Anesthesiology 49:428, 1978.
Collinsworth KA, Strong JM, Atkinson AJ, Jr., et al.: Pharmacokinetics and metabolism of lidocaine in patients with renal failure. Clin Pharm Therap 18:59, 1975.
Lowenthal DT: Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease. Am J Med 62:532, 1977.
Bianchetti G, Graziana G, Brancaccio D, et al.: Pharmacokinetics and effects of propranolol in terminal uremic patients and in patients undergoing regular dialysis treatment. Clin Pharm 1:373, 1976.
Bikhazi GB, Leung I, Foldes FF: Ca-channel blockers increase potency of neuromuscular blocking agents in vivo. Anesthesiology 59:A269, 1983.
Aldrete JA, Clapp HW, Starzl TE: Body temperature changes during organ transplantation. Anesth Analg 49:384, 1970.
Najarian JS, Simmons RL, Condie RM, et al.: Seven years’ experience with ALG for renal transplantation from cadaver donors. Ann Surg 184:352, 1976.
Lissoos I, Goldberg B, Vanblerk JP, et al.: Surgical procedures on patients in end-stage renal failure. Br J Urol 45:359, 1973.
Brenowitz JB, Williams CD, Edwards. WS: Major surgery in patients with chronic renal failure. Am J Surg 134:765, 1977.
Carlier M, Squifflet JP, Pirson Y, et al.: Maximal hydration during anesthesia increases pulmonary artery pressures and improves early function of human renal transplants. Transplantation 34:201, 1982.
Marsland AR, Bradley JP: Anesthesia for renal transplantation: five years’ experience. Anesth Inten Care 11:337, 1983.
Hampers CL, Bailey GL, Hager EB, et al.: Major surgery in patients on maintenance hemodialysis. Am J Surg 115:747, 1968.
Friedman M, Libert R, Michaelson ED: Unilateral pulmonary edema after renal transplantation. N Engl J Med 293:343, 1975.
Adrougue HJ, Madias NE: Changes in plasma potassium concentration during acute acid—base disturbances. Am J of Med 71:456, 1981.
Charters P: Renal transplantation in diabetes mellitus. Anaesthesia 35:199, 1981.
Hansen DD, Fernandes A, Skovsted P, et al.: Cyclopropane anesthesia for renal transplantation: report of 100 cases. Br J Anaesth 44:584, 1972.
D’Elia JA, Kaldany A, Miller DG, et al.: Moxalactam, bleeding, and renal insufficiency. JAMA 249:1565, 1983.
Carvalho ACA: Bleeding in uremia — a clinical challenge. N Engl J Med 308:38, 1983.
Janson PA, Jubelirer SJ, Weinstein J, et al.: Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303:1318, 1980.
Mannucci PM, Renuzzi G, Pusineri F, et al.: Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308:8, 1983.
Fernandez F, Goudable C, Sie P, et al.: Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59:139, 1985.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Bready, L.L. (1987). Postanesthetic Recovery. In: Graybar, G.B., Bready, L.L. (eds) Anesthesia for Renal Transplantation. Developments in Critical Care Medicine and Anesthesiology, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2035-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2035-7_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9211-1
Online ISBN: 978-1-4613-2035-7
eBook Packages: Springer Book Archive